MRGPRX2 and Adverse Drug Reactions

Area of Science:

• Pharmacology
• Immunology
• Dermatology

Background:

• Adverse drug reactions often resemble allergic responses.
• Traditional views attribute these to Immunoglobulin E (IgE) antibodies activating mast cells.
• An alternative pathway involving direct mast cell activation by drugs is increasingly recognized.

Purpose of the Study:

• To review drug-induced allergic-type events.
• To investigate the role of Mas-related G protein-coupled receptor X2 (MRGPRX2) activation.
• To assess the frequency, severity, and dose-response of MRGPRX2-mediated events.

Main Methods:

• Literature review of drugs with MRGPRX2 agonist activity.
• Analysis of reported allergic-type event frequency and severity.
• Comparison of plasma drug levels with event occurrence.

Main Results:

• Mild-to-moderate allergic-type events are more common than previously thought.
• MRGPRX2 activation correlates with many observed mild-to-moderate events.
• High drug doses may lead to predictable MRGPRX2 activation.

Conclusions:

• MRGPRX2 activation provides a non-IgE mechanism for drug-induced hypersensitivity.
• This pathway contributes significantly to common, mild-to-moderate adverse drug reactions.
• Understanding MRGPRX2 is crucial for predicting and managing drug side effects.